Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXF) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 31,100 shares, a drop of 42.0% from the October 31st total of 53,600 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 311.0 days.

Nicox Stock Performance

OTCMKTS NICXF remained flat at $0.24 on Thursday. The business has a fifty day moving average price of $0.39 and a 200-day moving average price of $0.42. Nicox has a one year low of $0.24 and a one year high of $0.24.

Nicox Company Profile

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.